Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 6/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | NCK1 | P16333 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | CCR1 | P32246 | 1/20 | 0.36 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
| ▸ | CCR8 | P51685 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29389285 | 0.76 | CYP1A2 (1.00) | CYP2A6CYP1A2TDP1ALDH1A1NCK1 | |
| SCHEMBL308248 | 0.76 | CYP1A2 (1.00) | CYP2A6CYP1A2TDP1ALDH1A1NCK1 | |
| M-Xylene SCHEMBL3470864 | 0.75 | ACHE (0.57) | CYP2A6CYP1A2TDP1ALDH1A1KDM4E | |
| Ammonia Solution, Strong SCHEMBL28805667 | 0.74 | CYP2A6 (0.93) | CYP2A6CYP1A2TDP1ALDH1A1NCK1 | |
| Methane SCHEMBL28761144 | 0.74 | CYP1A2 (0.93) | CYP2A6CYP1A2TDP1ALDH1A1NCK1 | |
| Water SCHEMBL27539226 | 0.74 | CYP1A2 (0.93) | CYP2A6CYP1A2TDP1ALDH1A1NCK1 | |
| SCHEMBL10882769 | 0.74 | CYP1A2 (0.93) | CYP2A6CYP1A2TDP1ALDH1A1NCK1 | |
| SCHEMBL29399131 | 0.74 | CYP1A2 (1.00) | CYP2A6CYP1A2TDP1ALDH1A1NCK1 | |
| SCHEMBL425085 | 0.74 | CYP1A2 (1.00) | CYP2A6CYP1A2TDP1ALDH1A1NCK1 | |
| SCHEMBL10882775 | 0.74 | CYP1A2 (0.93) | CYP2A6CYP1A2TDP1ALDH1A1NCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0269090-B1 | Highly conductive polymer composition and process for producing the same | SHOWA DENKO KK (JP) | 1994-02-02 | — | — | EP | claimed |
| US-4933106-A | NEUTRALIZED POLYISOTHIANAPHTHENE OR DERIVATIVE AND ANIONIC POLYMER ELECTROLYTE DOPANT | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1990-06-12 | — | — | US | claimed |
| US-4853380-A | REACTING SULFONATED HETEROCYCLIC SULFUR COMPOUNDS WITH DIAMINES OF PLATINUM NITRATE | INTERNATIONAL PHARMACEUTICAL PRODUCTS (US) | 1989-08-01 | — | — | US | claimed |
| US-20240067667-A1 | ORGANIC COMPOUND, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2024-02-29 | — | — | US | disclosed |
| US-20240067667-A1 | ORGANIC COMPOUND, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2024-02-29 | — | — | US | disclosed |
| EP-4129407-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
| US-11178870-B2 | Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients | MITSUI CHEMICALS AGRO, INC. (JP) | 2021-11-23 | — | — | US | disclosed |
| EP-3832763-A1 | POSITIVE ELECTRODE ACTIVE MATERIAL FOR MAGNESIUM BATTERIES | FUJIFILM Wako Pure Chemical Corporation (JP) | 2021-06-09 | — | — | EP | disclosed |
| WO-2020203594-A1 | FLUORENE DERIVATIVE AND USE THEREOF | 日産化学株式会社 | 2020-10-08 | — | — | WO | disclosed |
| US-10727534-B2 | Electrolyte solution containing magnesium ions | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2020-07-28 | — | — | US | disclosed |
| US-10683297-B2 | Substituted heteroaryl compounds and methods of use | CALITOR SCIENCES, LLC (US) | 2020-06-16 | — | — | US | disclosed |
| US-9796741-B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20160362399-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2016-12-15 | — | — | US | disclosed |
| WO-2015130838-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2015-09-03 | — | — | WO | disclosed |
| US-20150239895-A1 | Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Complement Mediated Disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2015-08-27 | — | — | US | disclosed |
| EP-1728256-A1 | CROSSLINKED SELF-DOPING TYPE ELECTRICALLY CONDUCTING POLYMER, PRODUCTION PROCESS THEREOF, PRODUCT COATED WITH THE POLYMER AND ELECTRONIC DEVICE | Showa Denko K.K. (JP) | 2006-12-06 | — | — | EP | disclosed |
| WO-2005091309-A1 | CROSSLINKED SELF-DOPING TYPE ELECTRICALLY CONDUCTING POLYMER, PRODUCTION PROCESS THEREOF, PRODUCT COATED WITH THE POLYMER AND ELECTRONIC DEVICE | SHOWA DENKO K.K. (JP) | 2005-09-29 | — | — | WO | disclosed |
| EP-0269090-B1 | Highly conductive polymer composition and process for producing the same | SHOWA DENKO KK (JP) | 1994-02-02 | — | — | EP | disclosed |
| US-4933106-A | NEUTRALIZED POLYISOTHIANAPHTHENE OR DERIVATIVE AND ANIONIC POLYMER ELECTROLYTE DOPANT | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1990-06-12 | — | — | US | disclosed |
| US-4853380-A | REACTING SULFONATED HETEROCYCLIC SULFUR COMPOUNDS WITH DIAMINES OF PLATINUM NITRATE | INTERNATIONAL PHARMACEUTICAL PRODUCTS (US) | 1989-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10727534-B2 | Electrolyte solution containing magnesium ions | MLX, PRDX1, PRDX6 | CYP2A6 389/4885CYP1A2 815/4885TDP1 2910/4885 |
| US-20240067667-A1 | ORGANIC COMPOUND, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE | ORC3, OR10J3, ESR1 | CYP2A6 265/4885CYP1A2 143/4885TDP1 406/4885 |
| US-11178870-B2 | Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients | PNPO, CYP4X1, PDXK | CYP2A6 42/4885CYP1A2 6/4885TDP1 945/4885 |
| US-10683297-B2 | Substituted heteroaryl compounds and methods of use | PRKACA, PRKDC, PRKACB | CYP2A6 1485/4885CYP1A2 1829/4885TDP1 988/4885 |
| US-20150239895-A1 | Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Complement Mediated Disorders | TFPI, CFD, F3 | CYP2A6 3737/4885CYP1A2 2103/4885TDP1 3474/4885 |
| US-20160362399-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | CFD, CFH, TFPI | CYP2A6 1329/4885CYP1A2 394/4885TDP1 3389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.